HHS Refers Providers to DOJ Over Gender-Affirming Care Billing Practices for Minors

The Department of Health and Human Services (HHS) has taken a significant step in scrutinizing the provision of gender-affirming care for minors. On Thursday, HHS announced that it had referred hundreds of healthcare organizations, including health systems, pediatric hospitals, physician groups, pharmacy benefits managers, specialty pharmacies, and Planned Parenthood affiliates, to federal law enforcement for investigation into their billing practices related to gender-affirming care.

The referrals come as part of a broader effort by the Trump administration to challenge what it views as medically dangerous and financially exploitative practices in the provision of gender-affirming care. The HHS report that prompted these referrals claims to expose coding practices that allowed providers to benefit financially, a position that stands at odds with leading medical associations.

HHS Secretary Robert F. Kennedy Jr. Emphasized the importance of putting children’s health first. "Doctors and hospitals must put children’s health ahead of ideology and financial gain," he stated. "This report identifies troubling billing practices that demand scrutiny. HHS will follow the evidence, protect taxpayers, and hold accountable anyone who broke the law or violated the trust of patients and families."

The report highlights specific insurance claims totaling about $50 million from 2015 through 2025 for minors’ puberty blockers. These claims were billed under the diagnostic code for unspecified Endocrine Disorder (E34.9), but on the same claim, No Gender Diagnosis (F64x) and No Precocious Puberty (E301). This combination of codes has raised suspicions of potentially anomalous billing practices.

The Debate Over Gender-Affirming Care

The HHS report and subsequent referrals have sparked a heated debate within the medical community. Leading organizations such as the American Academy of Pediatrics, the American Medical Association, and the American Psychological Association strongly support gender-affirming care for minors, citing extensive research that indicates these treatments can improve mental health outcomes and reduce the risk of suicide.

These organizations argue that the administration’s stance is based on ideological bias rather than scientific evidence. Dr. Susan Johnson, a pediatric endocrinologist and member of the American Academy of Pediatrics, stated, "The medical community has long recognized the importance of gender-affirming care in supporting the well-being of transgender youth. These referrals are politically motivated and could have serious consequences for patient access to necessary healthcare."

The controversy also extends to the broader issue of healthcare affordability and provider practices. According to a recent survey by HFMA, revenue cycle leaders from leading health systems are increasingly focused on shifting priorities and performance metrics. The integration of artificial intelligence (AI) is reshaping the future of the revenue cycle, but this technology must be used ethically and transparently to maintain patient trust.

Points to Watch

As the investigation unfolds, several key points will need close attention:

1. Impact on Patient Access: The referrals and potential investigations could disrupt access to gender-affirming care for minors. Providers may become more cautious or hesitant to offer these services, which could leave many young people without essential support.

2. Legal and Ethical Implications: The legal proceedings will likely raise important questions about the balance between regulatory oversight and medical autonomy. Healthcare providers will need to navigate a complex landscape of laws and ethical guidelines.

3. Public Perception and Policy: The public’s perception of gender-affirming care could be significantly influenced by the outcomes of these investigations. Policymakers will also be watching closely, as this case may set precedents for future healthcare regulations.

The HHS referrals mark a critical moment in the ongoing debate over gender-affirming care. As the medical community and policymakers grapple with these issues, the well-being of transgender youth remains at the heart of the discussion.